Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cozic

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Cancer|December 7, 2017
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 studyBas Vaarwerk, Johanna H van der Lee, Willemijn B Breunis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trialD Moro-Sibilot, N Cozic, M Pérol, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trialLaurence Brugières, Nathalie Cozic, Roch Houot, et al.
Neurology|April 8, 2016
A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystoniaElodie Hainque, Marie Vidailhet, Nathalie Cozic, et al.
British Journal of Cancer|January 15, 2024
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysisGwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2021
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamicsLaura Mezquita, Isabel Preeshagul, Edouard Auclin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Nature|October 22, 2025
Oxidative potential of atmospheric particles in Europe and exposure scenariosCécile Tassel, Jean-Luc Jaffrezo, Pamela Dominutti, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Cancer|December 7, 2017
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 studyBas Vaarwerk, Johanna H van der Lee, Willemijn B Breunis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trialD Moro-Sibilot, N Cozic, M Pérol, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trialLaurence Brugières, Nathalie Cozic, Roch Houot, et al.
Neurology|April 8, 2016
A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystoniaElodie Hainque, Marie Vidailhet, Nathalie Cozic, et al.
British Journal of Cancer|January 15, 2024
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysisGwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2021
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamicsLaura Mezquita, Isabel Preeshagul, Edouard Auclin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Nature|October 22, 2025
Oxidative potential of atmospheric particles in Europe and exposure scenariosCécile Tassel, Jean-Luc Jaffrezo, Pamela Dominutti, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
Pageof 8